Cited by 164Multiple Sclerosis Research StudiesGlaucoma and retinal disordersDrug-Induced Ocular Toxicity

Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study

Open access

Abstract

Objective: To determine the optimal thresholds for intereye differences in retinal nerve fiber and ganglion cell + inner plexiform layer thicknesses for identifying unilateral optic nerve lesions in multiple sclerosis. Current international diagnostic criteria for multiple sclerosis do not include the optic nerve as a lesion site despite frequent involvement. Optical coherence tomography detects retinal thinning associated with optic nerve lesions. Methods: In this multicenter international study at 11 sites, optical coherence tomography was measured for patients and healthy controls as part of the International Multiple Sclerosis Visual System Consortium. High‐ and low‐contrast acuity were also collected in a subset of participants. Presence of an optic nerve lesion for this study was defined as history of acute unilateral optic neuritis. Results: Among patients (n = 1,530), receiver operating characteristic curve analysis demonstrated an optimal peripapillary retinal nerve fiber layer intereye difference threshold of 5μm and ganglion cell + inner plexiform layer threshold of 4μm for identifying unilateral optic neuritis (n = 477). Greater intereye differences in acuities were associated with greater intereye retinal layer thickness differences ( p ≤ 0.001). Interpretation: Intereye differences of 5μm for retinal nerve fiber layer and 4μm for macular ganglion cell + inner plexiform layer are robust thresholds for identifying unilateral optic nerve lesions. These thresholds may be useful in establishing the presence of asymptomatic and symptomatic optic nerve lesions in multiple sclerosis and could be useful in a new version of the diagnostic criteria. Our findings lend further validation for utilizing the visual system in a multiple sclerosis clinical trial setting. Ann Neurol 2019;85:618–629

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.25462

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The optimal inter-eye difference threshold for identifying PwMS with known prior unilateral ON was 5μm for pRNFL (AUC = 0.74) and 4μm for GCIPL (AUC = 0.77) across OCT devices.

    “The optimal IED threshold for identifying PwMS with known prior unilateral ON for the pRNFL was 5µm (AUC = 0.74) and GCIPL was 4µm (AUC = 0.77) across OCT devices.”

    From The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis (2025) · cites this paper as [52]

    The available indexed passages identify the paper as a study of optimal intereye-difference thresholds, but do not report the claimed pRNFL and GCIPL thresholds or AUC values. Searches for unilateral optic neuritis, 5 μm, GCIPL, and AUC 0.74/0.77 found no passage that verifies those figures or the across-device qualifier. (LLM, conf=0.70)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. 10.1016/S1474-4422(17)30470-2 · DOI · Paper page
  2. 10.1212/NXI.0000000000000102 · DOI
  3. 10.1001/archneurol.2009.174 · DOI
  4. 10.1001/archneur.58.1.65 · DOI
  5. 10.1177/1352458509102617 · DOI
  6. 10.1212/NXI.0000000000000387 · DOI
  7. 10.1002/ana.24487 · DOI
  8. 10.1212/01.wnl.0000295995.46586.ae · DOI
  9. 10.1002/ana.22005 · DOI
  10. 10.1016/j.ophtha.2005.10.040 · DOI
  11. 10.1212/WNL.53.3.473 · DOI
  12. 10.1056/NEJMcp053247 · DOI
  13. Toussaint D, 1983, Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis, J Clin Neuroophthalmol, 3, 211
  14. 10.1212/WNL.26.6_Part_2.26 · DOI
  15. 10.1212/WNL.0b013e31827b1a1c · DOI
  16. 10.1016/S1474-4422(16)00068-5 · DOI
  17. 10.1016/S1474-4422(17)30278-8 · DOI · Paper page
  18. 10.1371/journal.pone.0036847 · DOI
  19. 10.3129/i10-063 · DOI
  20. 10.1016/j.jns.2009.02.354 · DOI
  21. Oberwahrenbrock T, 2012, Retinal damage in multiple sclerosis disease subtypes measured by high‐resolution optical coherence tomography, Mult Scler Int, 2012, 530305
  22. 10.1177/1352458512474706 · DOI
  23. 10.1007/s00415-016-8271-4 · DOI
  24. 10.1016/S0002-9394(02)01337-5 · DOI
  25. 10.1136/jnnp.2008.165449 · DOI
  26. 10.1016/j.ajo.2006.06.060 · DOI
  27. 10.1097/WNO.0000000000000421 · DOI
  28. 10.1177/1352458511418630 · DOI
  29. 10.1097/WNO.0b013e318238937f · DOI
  30. 10.1212/01.wnl.0000260612.51849.ed · DOI
  31. 10.1177/1352458508090221 · DOI
  32. 10.1016/j.ophtha.2011.11.032 · DOI
  33. 10.1167/iovs.03-1213 · DOI
  34. 10.1212/NXI.0000000000000449 · DOI
  35. 10.1097/WNO.0000000000000629 · DOI
  36. 10.1111/ene.13443 · DOI
  37. 10.1371/journal.pone.0137316 · DOI
  38. 10.1212/WNL.0000000000002774 · DOI
  39. 10.1177/1352458517690822 · DOI
  40. 10.2307/2531595 · DOI · Paper page
  41. 10.1016/j.ajo.2011.01.023 · DOI
  42. 10.1097/IJG.0000000000000203 · DOI
  43. 10.1016/S1474-4422(15)00393-2 · DOI · Paper page
  44. 10.1212/WNL.0000000000006207 · DOI
  45. 10.1016/S1474-4422(07)70176-X · DOI
  46. 10.1093/brain/awf087 · DOI
  47. Bhargava P, 2015, Applying an open‐source segmentation algorithm to different OCT devices in multiple sclerosis patients and healthy controls: implications for clinical trials, Mult Scler Int, 2015, 136295
  48. 10.1016/S1474-4422(10)70168-X · DOI

Cited by

Sorted by citations

Authors
Nolan‐Kenney, R. C., Liu, M., Akhand, O., Calabresi, P. A., Paul, F., Petzold, A., Balk, L., Brandt, A. U., Martínez‐Lapiscina, E. H., Saidha, S., Villoslada, P., Al‐Hassan, A. A., Behbehani, R., Frohman, E. M., Frohman, T., Havla, J., Hemmer, B., Jiang, H., Knier, B., Korn, T., Leocani, L., Papadopoulou, A., Pisa, M., Zimmermann, H., Galetta, S. L., Balcer, L. J., & on behalf of the International Multiple Sclerosis Visual System Consortium
Affiliations
  • Department of Population Health, Sackler Institute for Biomedical Sciences New York University School of Medicine New York NY
  • New York University (US)
  • NYU Langone Health (US)
  • Johns Hopkins University (US)
  • Max Delbrück Center (DE)
  • Moorfields Eye Hospital (GB)
  • University of California, Irvine (US)
  • Hospital Clínic de Barcelona (ES)
  • Dasman Diabetes Institute (KW)
  • The University of Texas at Austin (US)
  • Institut für Klinische Neuroimmunologie (DE)
  • Munich Cluster for Systems Neurology (DE)
  • University of Miami (US)
  • Technical University of Munich (DE)
  • Vita-Salute San Raffaele University (IT)
  • University Hospital of Basel (CH)
  • Humboldt-Universität zu Berlin (DE)
Corresponding author
Balcer, Laura J.
Venue
Annals of Neurology
Publisher
Wiley
Published
2019-04-10
Volume
85
Issue
5
Pages
618-629
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2922294220
Cited by
164
References
1
Citations by year
2026: 23 · 2025: 21 · 2024: 21 · 2023: 25 · 2022: 26 · 2021: 24 · 2020: 14 · 2019: 9
FWCI
13.43
Type
journal article
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • National Multiple Sclerosis Society (RG 4649A5/1)
  • Federal Ministry of Education and Research (01ZZ1804[A‐H], 01ZZ1603[A‐D])
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
Keywords
multiple sclerosis, optic nerve lesions, optic neuritis, retinal nerve fiber layer thickness, ganglion cell-inner plexiform layer thickness, optical coherence tomography, diagnostic criteria, visual function, visual acuity, retinal thinning
MeSH terms
Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Optic Nerve, Retinal Ganglion Cells, Visual Acuity, Cohort Studies, Internationality, Tomography, Optical Coherence, Retinal Neurons, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review